Divalen/monovalent bipolar cation therapy for enhancement of tis

Details Divalen/monovalent bipolar cation therapy for enhancement of tis Divalen/monovalent bipolar cation therapy for enhancement of tis

1978-06-19

1980-04-01

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

A61K 3726

Patent

active

041961960

ABSTRACT:
A composition for enhancing vascular perfusion and reperfusion in disease states, both in man and animals comprising an aqueous solution having a slightly acidic pH, and suitable for intravenous use and containing glucose, insulin and Magnesium dipotassium ethylene diamine tetraacetic acid (MgK.sub.2 EDTA).

REFERENCES:
patent: 2781291 (1957-02-01), Rubin et al.
patent: 3856771 (1974-12-01), Jackson
patent: 4041154 (1977-08-01), Helbig et al.

Affiliated with

Also associated with

Rating

Divalen/monovalent bipolar cation therapy for enhancement of tis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Divalen/monovalent bipolar cation therapy for enhancement of tis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Divalen/monovalent bipolar cation therapy for enhancement of tis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1313953